Using electroacupoint therapy to improve milk production in new mothers
Ameliorative Potential of Electroacupoint for Diminutive Milk Production in Lactating Woman
This study is testing if a new therapy that combines gentle electrical stimulation with diet changes can help new mothers who had a cesarean section produce more breast milk.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 25 Years to 30 Years |
| Sex | Female |
| Sponsor | Kafrelsheikh University Academic / other |
| Locations | 1 site (Kafrelsheikh) |
| Trial ID | NCT06590805 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of electroacupoint therapy on increasing milk production in lactating women who experience insufficient milk supply after cesarean delivery. The approach combines electrotherapy with dietary modifications, including the use of galactogogues like domperidone, while ensuring safety for both mother and child. Participants will be monitored for improvements in milk production and any potential side effects from the interventions. The study aims to provide a non-invasive alternative to traditional medications that may have adverse effects.
Who should consider this trial
Good fit: Ideal candidates are lactating women aged 25-30 who have experienced insufficient milk production within the first month after cesarean section.
Not a fit: Patients with underlying health conditions such as diabetes, breast cancer, or those who have had previous surgeries affecting breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a safer and more effective method for enhancing milk production in new mothers.
How similar studies have performed: While there have been various studies on lactation enhancement, the specific use of electroacupoint therapy in this context is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * They were complaining of insufficiency of lactation within the first month after cesarean section. * They are using mixed feeding; both breast and bottle feeding, between three and six bottles per day. * Their age ranged from 25-30 years old. * Their body mass index didn't exceeded 30 kg/m2. Exclusion Criteria: * Postpartum haemorrhage. * Cardiorespiratory disease. * Diabetes mellitus. * Breast cancer. * Previous surgeries in the chest, breast, or the surrounding area. * Anemia. * Any causes that hindered their normal breastfeeding (retraced, cracked, inflamed, or inverted nipples). * Receiving contraceptive pills. * Having infants with conditions that may affect the lactation process such as congenital abnormalities of the mouth (tongue tie, cleft palate). * Congenital heart disease.
Where this trial is running
Kafrelsheikh
- Kafrelsheikh University — Kafrelsheikh, Egypt (Recruiting)
Study contacts
- Study coordinator: Sara E Seyam, B.Sc.
- Email: saraseyam2024@gmail.com
- Phone: +201554552868
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.